Log in to save to my catalogue

Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital...

Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2495372546

Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies

About this item

Full title

Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies

Publisher

United States: Public Library of Science

Journal title

PloS one, 2021-03, Vol.16 (3), p.e0247789-e0247789

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Patients with restrictive or hypertrophic cardiomyopathy (RCM/HCM) and congenital heart disease (CHD) do not derive clinical benefit from inotropes and mechanical circulatory support. Concerns were expressed that the new heart allocation system implemented in October 2018 would disadvantage these patients. This paper aimed to examine the impact of...

Alternative Titles

Full title

Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2495372546

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2495372546

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0247789

How to access this item